{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:59:56Z","timestamp":1762527596165,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ajoc.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T15:31:34Z","timestamp":1486135894000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Conjunctival squamous papilloma refractory to interferon \u03b1-2b in a patient on systemic immunosuppression (tacrolimus)"],"prefix":"10.1016","volume":"6","author":[{"given":"Preethi S.","family":"Ganapathy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7835-3859","authenticated-orcid":false,"given":"Thomas","family":"Plesec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2017.01.005_bib1","series-title":"Clinical Ophthalmic Oncology: Conjunctival and Eyelid Tumors","article-title":"J.\u00a0Conjunctival and corneal tumors: ocular surface squamous neoplasia","author":"Pe\u2019er","year":"2014"},{"key":"10.1016\/j.ajoc.2017.01.005_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamaophthalmol.2013.83","article-title":"Conjunctival papilloma: features and outcomes based on age at initial examination","volume":"131","author":"Kaliki","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.01.005_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0002-9394(02)01514-3","article-title":"Treatment of conjunctival papillomata with topical interferon Alfa-2b","volume":"134","author":"Schechter","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.01.005_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9394(21)00234-8","article-title":"Interferon-alpha therapy of recurrent conjunctival papillomas","volume":"103","author":"Lass","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.01.005_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0002-9394(99)00221-4","article-title":"Treatment of recurrent conjunctival papillomatosis with mitomycin C","volume":"128","author":"Hawkins","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.01.005_bib6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/00003226-200211000-00023","article-title":"The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma","volume":"21","author":"Yuen","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2017.01.005_bib7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.biochi.2007.04.006","article-title":"Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use","volume":"89","author":"Ferrantini","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.ajoc.2017.01.005_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2008.12.035","article-title":"Conjunctival papilloma","volume":"116","author":"Tseng","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2017.01.005_bib9","first-page":"523","article-title":"Resolution of recurrent conjunctival papilloma after topical and intralesional interferon alpha2b with partial excision in a child","volume":"13","author":"Kothari","year":"2009","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.ajoc.2017.01.005_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IIO.0000000000000050","article-title":"Ocular surface squamous neoplasia: evidence for topical chemotherapy","volume":"55","author":"Pe'er","year":"2015","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ajoc.2017.01.005_bib11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","article-title":"Mode of action of tacrolimus (FK506): molecular and cellular mechanisms","volume":"17","author":"Thomson","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ajoc.2017.01.005_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/lt.21358","article-title":"Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells","volume":"14","author":"Hirano","year":"2008","journal-title":"Liver Transpl"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199361630161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199361630161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:56:11Z","timestamp":1762527371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245199361630161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":12,"alternative-id":["S245199361630161X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2017.01.005","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conjunctival squamous papilloma refractory to interferon \u03b1-2b in a patient on systemic immunosuppression (tacrolimus)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}